You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial
|
---|---|
Published in |
Trials, January 2013
|
DOI | 10.1186/1745-6215-14-273 |
Pubmed ID | |
Authors |
Immacolata Capasso, Emanuela Esposito, Nicola Maurea, Maurizio Montella, Anna Crispo, Michelino De Laurentiis, Massimiliano D’Aiuto, Giuseppe Frasci, Gerardo Botti, Maria Grimaldi, Ernesta Cavalcanti, Giuseppe Esposito, Alfredo Fucito, Giuseppe Brillante, Giuseppe D’Aiuto, Gennaro Ciliberto |
Abstract |
Inositol has been reported to improve insulin sensitivity since it works as a second messenger achieving insulin-like effects on metabolic enzymes. The aim of this study was to evaluate the inositol and alpha lipoic acid combination effectiveness on metabolic syndrome features in postmenopausal women at risk of breast cancer. |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 15% |
Brazil | 2 | 15% |
Spain | 1 | 8% |
United Kingdom | 1 | 8% |
Unknown | 7 | 54% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 11 | 85% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 167 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Italy | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 165 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 26 | 16% |
Student > Bachelor | 26 | 16% |
Researcher | 21 | 13% |
Student > Ph. D. Student | 12 | 7% |
Student > Postgraduate | 11 | 7% |
Other | 32 | 19% |
Unknown | 39 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 59 | 35% |
Nursing and Health Professions | 17 | 10% |
Agricultural and Biological Sciences | 16 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
Biochemistry, Genetics and Molecular Biology | 5 | 3% |
Other | 14 | 8% |
Unknown | 47 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2016.
All research outputs
#3,059,128
of 25,986,827 outputs
Outputs from Trials
#45
of 45 outputs
Outputs of similar age
#29,122
of 292,078 outputs
Outputs of similar age from Trials
#29
of 176 outputs
Altmetric has tracked 25,986,827 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 45 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,078 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 176 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.